A carregar...

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

We studied the activity of combined oxaliplatin and fluorouracil-leucovorin in 16 consecutive patients with advanced biliary tract adenocarcinomas. The disease control rate (responses and stable disease) was 56% (95% confidence interval, 29–84%) and the median overall survival time was 9.5 months (r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nehls, O, Klump, B, Arkenau, H T, Hass, H G, Greschniok, A, Gregor, M, Porschen, R
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2002
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364257/
https://ncbi.nlm.nih.gov/pubmed/12232749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!